162 related articles for article (PubMed ID: 34054042)
1. Management of Hyperleukocytosis in Childhood Acute Leukemia Without Leukapheresis and Rasburicase Prophylaxis.
Aylan Gelen S; Sarper N; Zengin E; Azizoğlu M
J Pediatr Hematol Oncol; 2022 Jan; 44(1):12-18. PubMed ID: 34054042
[TBL] [Abstract][Full Text] [Related]
2. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
[TBL] [Abstract][Full Text] [Related]
3. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
[TBL] [Abstract][Full Text] [Related]
4. Complications of "very high" leukocytosis in pediatric acute leukemia patients managed without rasburicase and leukopheresis.
Bakhshi S; Singh RB; Munot K; Pathania S
Indian J Pediatr; 2014 Aug; 81(8):817-20. PubMed ID: 24078288
[TBL] [Abstract][Full Text] [Related]
5. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
[TBL] [Abstract][Full Text] [Related]
6. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
Korkmaz S
Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
[TBL] [Abstract][Full Text] [Related]
7. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
[No Abstract] [Full Text] [Related]
9. Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis.
Creutzig U; Rössig C; Dworzak M; Stary J; von Stackelberg A; Wössmann W; Zimmermann M; Reinhardt D
Pediatr Blood Cancer; 2016 Apr; 63(4):640-5. PubMed ID: 26670831
[TBL] [Abstract][Full Text] [Related]
10. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
[TBL] [Abstract][Full Text] [Related]
11. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic leukocytapheresis in infants and children with leukemia and hyperleukocytosis: A single institution experience.
Thapa N; Pham R; Cole C; Meinershagen M; Bowman PW; Ray A
J Clin Apher; 2018 Jun; 33(3):316-323. PubMed ID: 29193219
[TBL] [Abstract][Full Text] [Related]
13. Rasburicase prevents tumor lysis syndrome despite extreme hyperleukocytosis.
Macfarlane RJ; McCully BJ; Fernandez CV
Pediatr Nephrol; 2004 Aug; 19(8):924-7. PubMed ID: 15179573
[TBL] [Abstract][Full Text] [Related]
14. The Role of Leukapheresis in the Current Management of Hyperleukocytosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia.
Nguyen R; Jeha S; Zhou Y; Cao X; Cheng C; Bhojwani D; Campbell P; Howard SC; Rubnitz J; Ribeiro RC; Sandlund JT; Gruber T; Inaba H; Pui CH; Metzger ML
Pediatr Blood Cancer; 2016 Sep; 63(9):1546-51. PubMed ID: 27187265
[TBL] [Abstract][Full Text] [Related]
15. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Bewersdorf JP; Zeidan AM
Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
[TBL] [Abstract][Full Text] [Related]
16. Treatment of impending tumor lysis with single-dose rasburicase.
Lee AC; Li CH; So KT; Chan R
Ann Pharmacother; 2003 Nov; 37(11):1614-7. PubMed ID: 14565793
[TBL] [Abstract][Full Text] [Related]
17. Leukapheresis in childhood acute leukemias: single-center experience.
Yilmaz D; Karapinar B; Karadaş N; Duyu M; Yazici P; Ay Y; Balkan C; Aydinok Y; Kavakli K
Pediatr Hematol Oncol; 2014 May; 31(4):318-26. PubMed ID: 23988130
[TBL] [Abstract][Full Text] [Related]
18. Rasburicase for the management of tumor lysis syndrome in neonates.
McNutt DM; Holdsworth MT; Wong C; Hanrahan JD; Winter SS
Ann Pharmacother; 2006; 40(7-8):1445-50. PubMed ID: 16868218
[TBL] [Abstract][Full Text] [Related]
19. Leukapheresis treatment in elderly acute leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Erkurt MA; Kuku I; Kaya E; Gozukara Bag H; Nizam I; Koroglu M; Yigit A; Ozgul M
J Clin Apher; 2016 Feb; 31(1):53-8. PubMed ID: 26011305
[TBL] [Abstract][Full Text] [Related]
20. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
